NCBI PubMed Central
open access
A Membrane-Centric Plasma Lipidomic Signature of Response to Long-Acting Naltrexone in Alcohol Use Disorder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Naltrexone Effects on Alcohol Intake#841258
- The neurobiological cravings signature (NCS) as a predictive neuromarker of clinical outcomes in alcohol use disorder#253603
- Physiological Study of the Efficacy and Mechanistic Effects of Alcohol Renal Denervation#463622
- Daridorexant for Alcohol Use Disorder#892276
- Fenofibrate - A lipid-lowering drug - Reduces voluntary alcohol drinking in rats#947676
Record · ID 182301
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive